I-VASC

I-VASC S.r.l. has decades of experience in innovative minimally invasive devices, from product development to clinical application, market access, and global commercialization. It aims to introduce its patented Empty Vein Ablation (EVA) technology for minimally invasive varicose vein treatment to the global market. The company's main product, VELEX™, is I-VASC’s first CE-marked approved device, offering an innovative solution using Empty Vein Ablation (EVA) technology for the treatment of Chronic Venous Insufficiency (CVI), particularly including varicose vein conditions.